1.14
Fattori che influenzano la risposta ai farmaci: panoramica
Quando si tratta di neonati e bambini piccoli, di solito vengono somministrate dosi più piccole di farmaci rispetto agli adulti. Questo avviene princi…
Rispetto agli adulti, ai neonati e ai bambini piccoli vengono somministrate dosi di farmaco più piccole poiché le loro funzioni organiche non sono completamente sviluppate e i farmaci non vengono metabolizzati o eliminati in modo efficiente.
Inoltre, la loro barriera emato-encefalica è più permeabile e alte concentrazioni di farmaci nel SNC possono causare danni neurologici.
Ai pazienti anziani vengono somministrate dosi più piccole di farmaco poiché l'invecchiamento influenza la disposizione dei farmaci. Se un paziente anziano con diverse malattie croniche assume più farmaci, può portare a diverse reazioni avverse.
Nelle donne in gravidanza, i farmaci possono passare attraverso la placenta, con conseguenti effetti teratogeni nel feto in via di sviluppo.
Nei pazienti con malattia epatica, si raccomandano dosi più basse del farmaco per intervalli più lunghi perché un fegato compromesso non può metabolizzare o disintossicare il farmaco in modo efficiente.
I farmaci somministrati per via endovenosa entrano direttamente nel flusso sanguigno, bypassando il tratto gastrointestinale e il metabolismo epatico, quindi la risposta al farmaco è rapida.
Al contrario, i farmaci assunti per via orale passano attraverso il tratto gastrointestinale e subiscono il metabolismo epatico prima di entrare nella circolazione sistemica. Tali farmaci mostrano una risposta lenta.
View the full transcript and gain access to JoVE Core videos
Q1: Why do infants and young children receive smaller drug doses than adults?
Infants and young children have underdeveloped organ functions, making them less efficient at metabolizing and eliminating drugs. Additionally, their blood-brain barrier is more permeable, allowing high drug concentrations to penetrate the central nervous system and potentially cause neurological damage. Smaller doses protect developing systems from harm.
Q2: How does aging affect drug dosing in elderly patients?
Aging significantly influences drug disposition, requiring elderly patients to receive smaller doses. When elderly patients with multiple chronic diseases take numerous medications simultaneously, the risk of adverse reactions increases substantially. Dose adjustments account for reduced metabolic capacity and increased drug sensitivity.
Q3: What are the risks of drug exposure during pregnancy?
Drugs can cross the placenta and reach the developing fetus, potentially causing teratogenic effects that result in fetal developmental abnormalities. This placental transfer poses significant risks to fetal health and development. Pregnant women require careful medication selection and dosing to minimize fetal exposure.
Q4: Why do patients with liver disease need modified drug dosing?
A damaged liver cannot efficiently metabolize or detoxify drugs, so patients with liver disease require lower doses administered over longer intervals. This modification prevents drug accumulation and reduces the risk of toxicity. Hepatic impairment significantly slows drug elimination from the body.
Q5: How does the route of drug administration affect drug response speed?
Intravenous administration allows drugs to enter the bloodstream directly, bypassing the gastrointestinal tract and hepatic metabolism, resulting in a quick drug response. Oral drugs must pass through the GI tract and undergo hepatic metabolism before entering systemic circulation, producing a slower response. Routes of drug administration overview explains these differences in detail.
Q6: What happens to orally administered drugs before they reach the bloodstream?
Orally administered drugs pass through the gastrointestinal tract where they are absorbed, then undergo hepatic metabolism in the liver before entering the systemic circulation. This first-pass metabolism can reduce drug bioavailability and delay therapeutic effects. Understanding routes of drug administration enteral helps clarify this process.
Q7: How does drug metabolism differ between intravenous and oral administration?
Intravenous drugs bypass hepatic metabolism entirely by entering the bloodstream directly, avoiding first-pass metabolism. Oral drugs undergo hepatic metabolism before systemic circulation, which can significantly alter drug concentration and effectiveness. This metabolic difference explains why intravenous administration produces faster therapeutic responses than oral routes.